In 2002, Mark Taylor, a Survivor of the Columbine High

In 2002, Mark Taylor, a survivor of the Columbine High School shooting, sued the pharmaceutical company that manufactures Luvox, an antidepressant drug that one of the shooters was taking at the time of the shooting. How did the case conclude?

A) Based on the testimony of Peter Breggin, M.D., the court ordered the pharmaceutical company to pay a fine and recall the product.
B) Taylor dropped his lawsuit in exchange for a contribution from the pharmaceutical company to the American Cancer Society.
C) The case remains inconclusive after several experts criticized Peter Breggin's testimony as baseless.
D) The court decided in favor of the pharmaceutical company, once the motion to exclude Breggin's testimony was granted.